Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Sarcoma ; 2020: 8647981, 2020.
Article in English | MEDLINE | ID: mdl-32300280

ABSTRACT

Rhabdomyosarcoma (RMS) and rhabdoid tumors (RT) are rare soft-tissue malignancies with the highest incidence in infants, children, and adolescents. Advanced, recurrent, and/or metastatic RMS and RT exhibit poor response to treatment. One of the main mechanisms behind resistance to treatment is believed to be intratumoral heterogeneity. In this study, we investigated the myogenic determination factor 1 (MYOD1) and Noggin (NOG) markers in an embryonal RMS (ERMS) cell line and an RT cell line and the differential response of the MYOD1 and NOG expressing subpopulations to chemotherapy. Importantly, we found that these markers together identify a subpopulation of cells (MYOD1+ NOG+ cells) with primary resistance to Vincristine and Doxorubicin, two commonly used chemotherapies for ERMS and RT. The chemoresistant MYOD1+ NOG+ cells express markers of undifferentiated cells such as myogenin and ID1. Combination of Vincristine with TPA/GSK126, a drug combination shown to induce differentiation of RMS cell lines, is able to partially overcome MYOD1/NOG cells chemoresistance.

2.
Eur J Immunol ; 46(7): 1752-7, 2016 07.
Article in English | MEDLINE | ID: mdl-27105894

ABSTRACT

A unique population of CD23(+) CD21(high) B cells in inflamed nodes (Bin) has been shown to accumulate in lymph nodes (LNs) draining inflamed joints of TNF-transgenic (TNF-tg) mice. Bin cells contribute to arthritis flare in mice by distorting node architecture and hampering lymphatic flow, but their existence in human inflamed LNs has not yet been described. Here, we report the characterization of resident B-cell populations in fresh popliteal lymph nodes (PLNs) from patients with severe lower limb diseases (non-RA) and rheumatoid arthritis (RA) patients, and from banked, cryopreserved reactive and normal human LN single cell suspension samples. Bin-like B cells were shown to be significantly increased in reactive LNs, and strikingly elevated (>30% of total) in RA samples. Histopathology and immunofluorescence analyses were consistent with B follicular hyperplasia and histological alterations in RA vs. non-RA PLNs. This is the first description of Bin-like B cells in human inflamed LNs. Consistent with published mouse data, this population appears to be associated with inflammatory arthritis and distortion of LN architecture. Further analyses are necessary to assess the role of CD23(+) CD21(hi) Bin-like B cells in RA pathogenesis and arthritic flare.


Subject(s)
Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/metabolism , B-Lymphocyte Subsets/immunology , B-Lymphocyte Subsets/metabolism , Lymph Nodes/immunology , Lymph Nodes/metabolism , Receptors, Complement 3d/metabolism , Receptors, IgE/metabolism , Animals , Arthritis, Rheumatoid/pathology , Biomarkers , Humans , Immunophenotyping , Lymph Nodes/pathology , Lymphocyte Count , Mice , Mice, Transgenic
3.
Cell Immunol ; 296(2): 133-7, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25959608

ABSTRACT

Tumor necrosis factor (TNF) is a key cytokine in rheumatoid arthritis (RA) pathogenesis, as underscored by the clinical effectiveness of TNF antagonists. While several of TNF's key targets in RA are well understood, its many pleiotropic effects remain to be elucidated. TNF-transgenic mice develop inflammatory-erosive arthritis associated with disruption of draining lymph node histology and function, and accumulation of B cells with unique phenotypic and functional features consistent with contribution to pathogenesis (B cells in inflamed nodes, Bin). Bin cell induction depends on the inflamed microenvironment, but the specific signals are unknown. Using anti-TNF treatment and TNF-receptor-deficient mice, here we show that Bin cells are induced and maintained independently of B cell-intrinsic TNF signals.


Subject(s)
Antibodies/pharmacology , Arthritis, Experimental/immunology , B-Lymphocytes/immunology , Lymph Nodes/immunology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adoptive Transfer , Animals , Antigens, CD1d/genetics , Antigens, CD1d/immunology , Arthritis, Experimental/drug therapy , Arthritis, Experimental/genetics , Arthritis, Experimental/pathology , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/pathology , B-Lymphocytes/drug effects , B-Lymphocytes/pathology , B-Lymphocytes/transplantation , Cellular Microenvironment/immunology , Gene Expression , Humans , Immunophenotyping , Lymph Nodes/drug effects , Lymph Nodes/pathology , Lymphocyte Count , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, Complement 3b/genetics , Receptors, Complement 3b/immunology , Receptors, Complement 3d/genetics , Receptors, Complement 3d/immunology , Receptors, IgE/genetics , Receptors, IgE/immunology , Receptors, Tumor Necrosis Factor, Type I/deficiency , Receptors, Tumor Necrosis Factor, Type I/genetics , Receptors, Tumor Necrosis Factor, Type I/immunology , Receptors, Tumor Necrosis Factor, Type II/deficiency , Receptors, Tumor Necrosis Factor, Type II/genetics , Receptors, Tumor Necrosis Factor, Type II/immunology , Signal Transduction , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology
4.
J Immunol ; 188(12): 5944-53, 2012 Jun 15.
Article in English | MEDLINE | ID: mdl-22593620

ABSTRACT

CD23(+)CD21(high)CD1d(high) B cells in inflamed nodes (Bin cells) accumulate in the lymph nodes (LNs) draining inflamed joints of the TNF-α-transgenic mouse model of rheumatoid arthritis and are primarily involved in the significant histological and functional LN alterations that accompany disease exacerbation in this strain. In this study, we investigate the origin and function of Bin cells. We show that adoptively transferred GFP(+) sorted mature follicular B (FoB) cells home preferentially to inflamed LNs of TNF-α-transgenic mice where they rapidly differentiate into Bin cells, with a close correlation with the endogenous Bin fraction. Bin cells are also induced in wild-type LNs after immunization with T-dependent Ags and display a germinal center phenotype at higher rates compared with FoB cells. Furthermore, we show that Bin cells can capture and process Ag-immune complexes in a CD21-dependent manner more efficiently than can FoB cells, and they express greater levels of MHC class II and costimulatory Ags CD80 and CD86. We propose that Bin cells are a previously unrecognized inflammation-induced B cell population with increased Ag capture and activation potential, which may facilitate normal immune responses but may contribute to autoimmunity when chronic inflammation causes their accumulation and persistence in affected LNs.


Subject(s)
Arthritis, Experimental/immunology , B-Lymphocyte Subsets/immunology , B-Lymphocytes/immunology , Lymph Nodes/cytology , Lymphocyte Activation/immunology , Adoptive Transfer , Animals , Antigen Presentation/immunology , Antigens, CD1d/immunology , Antigens, CD1d/metabolism , Arthritis, Rheumatoid/immunology , B-Lymphocyte Subsets/cytology , B-Lymphocyte Subsets/metabolism , B-Lymphocytes/cytology , B-Lymphocytes/metabolism , Cell Differentiation/immunology , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Inflammation/immunology , Inflammation/metabolism , Lymph Nodes/immunology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Receptors, Complement 3d/immunology , Receptors, Complement 3d/metabolism , Receptors, IgE/immunology , Receptors, IgE/metabolism
5.
Leuk Res ; 35(6): 800-7, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21074852

ABSTRACT

Allogeneic hematopoietic stem cell transplantation is often performed for patients with acute lymphoblastic leukemia (ALL) whose disease has relapsed after chemotherapy treatment. However, graft versus leukemia (GVL) effects in ALL are generally weak and the mechanisms of this weakness are unknown. These studies tested the hypothesis that ALL cells that have survived conventional chemotherapy in vivo acquire relative resistance to the allogeneic GVL effect. C57BL/6 mice were injected with murine pre-B ALL lines driven by human mutations and then were treated with combination chemotherapy. ALL cells surviving therapy were analysed in vitro and in vivo for acquisition of resistance to chemotherapy, radiation, cytolytic T cells, NK cells, LAK cells and cytokines. In vivo drug treatment did lead to leukemia population with more rapid proliferation and also decreased sensitivity to vincristine, doxorubicin and radiation. However, drug treatment did not produce ALL populations that were less sensitive to GVL effects in vitro or in vivo.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Graft vs Leukemia Effect/immunology , Hematopoietic Stem Cell Transplantation/methods , Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy , Animals , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Proliferation/radiation effects , Cell Survival/drug effects , Cell Survival/radiation effects , Cells, Cultured , Cytotoxicity, Immunologic/immunology , Female , Flow Cytometry , Humans , Interferon-alpha/pharmacology , Killer Cells, Natural/immunology , Mice , Mice, Inbred C57BL , Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Survival Analysis , T-Lymphocytes, Cytotoxic/immunology , Transplantation, Homologous , Whole-Body Irradiation
6.
J Immunol ; 180(11): 7443-50, 2008 Jun 01.
Article in English | MEDLINE | ID: mdl-18490744

ABSTRACT

The intronic Emicro enhancer has been implicated in IgH locus transcription, VDJ recombination, class switch recombination, and somatic hypermutation. How Emicro controls these diverse mechanisms is still largely unclear, but transcriptional enhancer activity is thought to play a central role. In this study we compare the phenotype of mice lacking the Emicro element (DeltaEmicro) with that of mice in which Emu was replaced with the ubiquitous SV40 transcriptional enhancer (SV40eR mutation) and show that SV40e cannot functionally complement Emu loss in pro-B cells. Surprisingly, in fact, the SV40eR mutation yields a more profound defect than DeltaEmicro, with an almost complete block in micro0 germline transcription in pro-B cells. This active transcriptional suppression caused by enhancer replacement appears to be specific to the early stages of B cell development, as mature SV40eR B cells express micro0 transcripts at higher levels than DeltaEmicro mice and undergo complete DNA demethylation at the IgH locus. These results indicate an unexpectedly stringent, developmentally restricted requirement for enhancer specificity in regulating IgH function during the early phases of B cell differentiation, consistent with the view that coordination of multiple independent regulatory mechanisms and elements is essential for locus activation and VDJ recombination.


Subject(s)
B-Lymphocytes/metabolism , Enhancer Elements, Genetic , Gene Rearrangement, B-Lymphocyte, Heavy Chain , Genes, Immunoglobulin Heavy Chain , Immunoglobulin Heavy Chains/genetics , Alleles , Animals , B-Lymphocytes/cytology , B-Lymphocytes/immunology , Bone Marrow , Cell Line , DNA Methylation , Immunoglobulin Heavy Chains/immunology , Immunoglobulin Heavy Chains/metabolism , Mice , Mice, Mutant Strains , Mutation , Recombination, Genetic , Spleen , Transcription, Genetic
7.
Eur J Immunol ; 34(7): 1807-16, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15214029

ABSTRACT

Immunoglobulin (Ig) isotype deficiencies are among the most common and least characterized humoral immunodeficiencies. A thorough understanding of their immunological and genetic features has been hampered by their extreme heterogeneity and the paucity of suitable animal models. Here, we report the initial characterization of a new mouse model with selective Ig deficiency. SENCARA mice display low serum IgG3 levels as well as severely deficient IgG3 responses to T cell-independent (TI) type 1 and 2 antigens. However, despite the significant block in class switching, expression of activation-induced deaminase and gamma3 germ-line transcription after TI antigen immunization are normal. IgG3 production in response to in vitro LPS stimulation was also normal, ruling out a specific defect in the Cgamma3 switch machinery. A decrease in the number of peritoneal B1a cells and enlarged splenic marginal zones were observed. The immunodeficiency is inherited as an autosomal, semi-dominant, essentially monogenic trait in SENCARA x C57BL/6 crosses. The SENCARA humoral immunodeficiency constitutes a novel immune phenotype, resembling human conditions such as IgG2 deficiency. This new mouse model will be of interest for the understanding of mechanisms involved in TI immune responses and may provide new insights into the molecular basis of human Ig deficiencies.


Subject(s)
Antigens, T-Independent/immunology , B-Lymphocyte Subsets/immunology , B-Lymphocyte Subsets/metabolism , Immunoglobulin Class Switching , Immunologic Deficiency Syndromes/immunology , Animals , B-Lymphocyte Subsets/cytology , Cell Division , Cells, Cultured , Disease Models, Animal , Female , Immunoglobulin G/blood , Immunoglobulin G/immunology , Immunologic Deficiency Syndromes/blood , Immunologic Deficiency Syndromes/pathology , Male , Mice , Mice, Inbred SENCAR , Models, Immunological , Spleen/cytology , Spleen/immunology , T-Lymphocytes/immunology
8.
J Immunol Methods ; 278(1-2): 211-9, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12957409

ABSTRACT

Lipid rafts are specialized micro-domains of the plasma membrane enriched in glycosphingolipid and cholesterol that play important role in signal transduction, membrane trafficking, and cell adhesion. A distinct feature of lipid rafts is their resistance to solubilization with non-ionic detergent Triton X-100 (TX-100). In this study, we used flow cytometry to evaluate TX-100 resistance of 74 cell membrane molecules expressed on normal human peripheral blood lymphocytes (PBL), thymocytes, and 12 lymphoid cell lines. Resistance of membrane molecules to solubilization with TX-100 was determined by comparing the intensities of fluorescence of cells treated with TX-100 or left untreated. The majority of antigens analyzed were easily solubilized with TX-100 that resulted in decreased fluorescence intensity. However, a group of antigens showed TX-100 resistance in the range of 20-100%. These included all glycosylphosphatidylinositol (GPI)-anchored antigens under study, as well as some glycolipid and trans-membrane antigens. With the few exceptions, antigen resistance to solubilization with TX-100 was stable parameter, which did not depend on cell type in which it was analyzed. There was a good correspondence between the antigens showing resistance to solubilization with TX-100 as evaluated by our flow cytometry method, and the antigens that were previously demonstrated in detergent-resistant membranes using a more standard method of physical fractionation. Taken collectively, our data suggest that flow cytometry is a useful method for rapid evaluation of the possible association of a membrane antigen with lipid rafts.


Subject(s)
Flow Cytometry , Lymphocytes/drug effects , Membrane Microdomains/metabolism , Octoxynol/pharmacology , Surface-Active Agents/pharmacology , Antibodies/immunology , Antigens, Surface/drug effects , Antigens, Surface/immunology , Biomarkers , Cell Line , Cell Membrane/drug effects , Fluorescent Antibody Technique , Humans , Microscopy, Confocal , Solubility
SELECTION OF CITATIONS
SEARCH DETAIL
...